# DONALDSON Co INC: financial statements, quarterly DCI · NYSE · CIK 29644 · [Industrials](/sectors/industrials.md) · fiscal year ends Jul 31 Pages: [Overview](/companies/dci.md) · [Financials](/companies/dci/financials.md) · [Filings](/companies/dci/filings.md) · [Insiders](/companies/dci/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dci/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [846](/filings/0000029644-24-000181.md) | [877](/filings/0000029644-25-000029.md) | [928](/filings/0000029644-25-000058.md) | [935 d](/filings/0000029644-26-000085.md) | [900](/filings/0000029644-25-000147.md) | [870](/filings/0000029644-26-000026.md) | [940](/filings/0000029644-26-000052.md) | [981 d](/filings/0000029644-26-000085.md) | [935](/filings/0000029644-25-000147.md) | [896](/filings/0000029644-26-000026.md) | [995](/filings/0000029644-26-000052.md) | [1,059 d](/filings/0000029644-26-000085.md) | | Cost of revenue | $m | [545](/filings/0000029644-24-000181.md) | [568](/filings/0000029644-25-000029.md) | [598](/filings/0000029644-25-000058.md) | [601 d](/filings/0000029644-26-000085.md) | [581](/filings/0000029644-25-000147.md) | [564](/filings/0000029644-26-000026.md) | [618](/filings/0000029644-26-000052.md) | [642 d](/filings/0000029644-26-000085.md) | [607](/filings/0000029644-25-000147.md) | [597](/filings/0000029644-26-000026.md) | [662](/filings/0000029644-26-000052.md) | [675 d](/filings/0000029644-26-000085.md) | | Gross profit | $m | [301](/filings/0000029644-24-000181.md) | [309](/filings/0000029644-25-000029.md) | [330](/filings/0000029644-25-000058.md) | [335 d](/filings/0000029644-26-000085.md) | [320](/filings/0000029644-25-000147.md) | [306](/filings/0000029644-26-000026.md) | [322](/filings/0000029644-26-000052.md) | [339 d](/filings/0000029644-26-000085.md) | [329](/filings/0000029644-25-000147.md) | [300](/filings/0000029644-26-000026.md) | [333](/filings/0000029644-26-000052.md) | [384 d](/filings/0000029644-26-000085.md) | | Research and development | $m | [21.3](/filings/0000029644-24-000181.md) | [22.1](/filings/0000029644-25-000029.md) | [24.8](/filings/0000029644-25-000058.md) | [25.4 d](/filings/0000029644-26-000085.md) | [22.7](/filings/0000029644-25-000147.md) | [21.2](/filings/0000029644-26-000026.md) | [21.4](/filings/0000029644-26-000052.md) | [22.5 d](/filings/0000029644-26-000085.md) | [19.2](/filings/0000029644-25-000147.md) | [18.6](/filings/0000029644-26-000026.md) | [19.2](/filings/0000029644-26-000052.md) | [19.1 d](/filings/0000029644-26-000085.md) | | Selling, general and administrative | $m | [155](/filings/0000029644-24-000181.md) | [157](/filings/0000029644-25-000029.md) | [162](/filings/0000029644-25-000058.md) | [163 d](/filings/0000029644-26-000085.md) | [166](/filings/0000029644-25-000147.md) | [159](/filings/0000029644-26-000026.md) | [152](/filings/0000029644-26-000052.md) | [165 d](/filings/0000029644-26-000085.md) | [170](/filings/0000029644-25-000147.md) | [163](/filings/0000029644-26-000026.md) | [159](/filings/0000029644-26-000052.md) | [188 d](/filings/0000029644-26-000085.md) | | Operating income | $m | [125](/filings/0000029644-24-000181.md) | [130](/filings/0000029644-25-000029.md) | [144](/filings/0000029644-25-000058.md) | [146 d](/filings/0000029644-26-000085.md) | [131](/filings/0000029644-25-000147.md) | [126](/filings/0000029644-26-000026.md) | [87.4](/filings/0000029644-26-000052.md) | [152 d](/filings/0000029644-26-000085.md) | [149](/filings/0000029644-25-000147.md) | [119](/filings/0000029644-26-000026.md) | [155](/filings/0000029644-26-000052.md) | [177 d](/filings/0000029644-26-000085.md) | | Interest expense | $m | [5.5](/filings/0000029644-23-000136.md) | [5.6](/filings/0000029644-24-000027.md) | [5.0](/filings/0000029644-24-000067.md) | [5.3 d](/filings/0000029644-26-000085.md) | [5.5](/filings/0000029644-25-000147.md) | [5.9](/filings/0000029644-26-000026.md) | [5.7](/filings/0000029644-26-000052.md) | [7.1 d](/filings/0000029644-26-000085.md) | [7.1](/filings/0000029644-25-000147.md) | [7.7](/filings/0000029644-26-000026.md) | [6.5](/filings/0000029644-26-000052.md) | [14.7 d](/filings/0000029644-26-000085.md) | | Income tax | $m | [30.8](/filings/0000029644-24-000181.md) | [30.3](/filings/0000029644-25-000029.md) | [30.5](/filings/0000029644-25-000058.md) | [29.7 d](/filings/0000029644-26-000085.md) | [31.5](/filings/0000029644-25-000147.md) | [29.1](/filings/0000029644-26-000026.md) | [29.2](/filings/0000029644-26-000052.md) | [35.4 d](/filings/0000029644-26-000085.md) | [33.6](/filings/0000029644-25-000147.md) | [24.1](/filings/0000029644-26-000026.md) | [36.7](/filings/0000029644-26-000052.md) | [37.6 d](/filings/0000029644-26-000085.md) | | Net income | $m | [92.1](/filings/0000029644-24-000181.md) | [98.7](/filings/0000029644-25-000029.md) | [114](/filings/0000029644-25-000058.md) | [110 d](/filings/0000029644-26-000085.md) | [99.0](/filings/0000029644-25-000147.md) | [95.9](/filings/0000029644-26-000026.md) | [57.8](/filings/0000029644-26-000052.md) | [114 d](/filings/0000029644-26-000085.md) | [114](/filings/0000029644-25-000147.md) | [92.5](/filings/0000029644-26-000026.md) | [118](/filings/0000029644-26-000052.md) | [129 d](/filings/0000029644-26-000085.md) | | Diluted EPS | $ per share | [0.75](/filings/0000029644-24-000181.md) | [0.81](/filings/0000029644-25-000029.md) | [0.92](/filings/0000029644-25-000058.md) | not reported | [0.81](/filings/0000029644-25-000147.md) | [0.79](/filings/0000029644-26-000026.md) | [0.48](/filings/0000029644-26-000052.md) | not reported | [0.97](/filings/0000029644-25-000147.md) | [0.78](/filings/0000029644-26-000026.md) | [1.00](/filings/0000029644-26-000052.md) | not reported | | Basic EPS | $ per share | [0.76](/filings/0000029644-24-000181.md) | [0.82](/filings/0000029644-25-000029.md) | [0.94](/filings/0000029644-25-000058.md) | not reported | [0.83](/filings/0000029644-25-000147.md) | [0.80](/filings/0000029644-26-000026.md) | [0.49](/filings/0000029644-26-000052.md) | not reported | [0.98](/filings/0000029644-25-000147.md) | [0.80](/filings/0000029644-26-000026.md) | [1.02](/filings/0000029644-26-000052.md) | not reported | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [218](/filings/0000029644-23-000136.md) | [194](/filings/0000029644-24-000027.md) | [224](/filings/0000029644-24-000067.md) | [233](/filings/0000029644-25-000098.md) | [221](/filings/0000029644-24-000181.md) | [189](/filings/0000029644-25-000029.md) | [179](/filings/0000029644-25-000058.md) | [180](/filings/0000029644-26-000085.md) | [211](/filings/0000029644-25-000147.md) | [194](/filings/0000029644-26-000026.md) | [204](/filings/0000029644-26-000052.md) | [250](/filings/0000029644-26-000085.md) | | Current assets | $m | [1,313](/filings/0000029644-23-000136.md) | [1,317](/filings/0000029644-24-000027.md) | [1,401](/filings/0000029644-24-000067.md) | [1,438](/filings/0000029644-25-000098.md) | [1,479](/filings/0000029644-24-000181.md) | [1,423](/filings/0000029644-25-000029.md) | [1,476](/filings/0000029644-25-000058.md) | [1,462](/filings/0000029644-26-000085.md) | [1,514](/filings/0000029644-25-000147.md) | [1,527](/filings/0000029644-26-000026.md) | [1,573](/filings/0000029644-26-000052.md) | [1,670](/filings/0000029644-26-000085.md) | | Total assets | $m | [2,769](/filings/0000029644-23-000136.md) | [2,784](/filings/0000029644-24-000027.md) | [2,866](/filings/0000029644-24-000067.md) | [2,914](/filings/0000029644-25-000098.md) | [3,044](/filings/0000029644-24-000181.md) | [2,961](/filings/0000029644-25-000029.md) | [2,997](/filings/0000029644-25-000058.md) | [2,977](/filings/0000029644-26-000085.md) | [3,027](/filings/0000029644-25-000147.md) | [3,060](/filings/0000029644-26-000026.md) | [3,088](/filings/0000029644-26-000052.md) | [3,987](/filings/0000029644-26-000085.md) | | Current liabilities | $m | [883](/filings/0000029644-23-000136.md) | [894](/filings/0000029644-24-000027.md) | [735](/filings/0000029644-24-000067.md) | [783](/filings/0000029644-25-000098.md) | [801](/filings/0000029644-24-000181.md) | [766](/filings/0000029644-25-000029.md) | [760](/filings/0000029644-25-000058.md) | [757](/filings/0000029644-26-000085.md) | [704](/filings/0000029644-25-000147.md) | [666](/filings/0000029644-26-000026.md) | [669](/filings/0000029644-26-000052.md) | [804](/filings/0000029644-26-000085.md) | | Total liabilities | $m | [1,433](/filings/0000029644-23-000136.md) | [1,408](/filings/0000029644-24-000027.md) | [1,382](/filings/0000029644-24-000067.md) | [1,425](/filings/0000029644-25-000098.md) | [1,501](/filings/0000029644-24-000181.md) | [1,417](/filings/0000029644-25-000029.md) | [1,532](/filings/0000029644-25-000058.md) | [1,524](/filings/0000029644-26-000085.md) | [1,510](/filings/0000029644-25-000147.md) | [1,485](/filings/0000029644-26-000026.md) | [1,392](/filings/0000029644-26-000052.md) | [2,222](/filings/0000029644-26-000085.md) | | Long-term debt | $m | not reported | not reported | not reported | [510](/filings/0000029644-24-000111.md) | not reported | not reported | not reported | [640](/filings/0000029644-25-000098.md) | not reported | not reported | not reported | [1,283](/filings/0000029644-26-000085.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | [74.6](/filings/0000029644-23-000136.md) | [50.4](/filings/0000029644-24-000027.md) | [49.4](/filings/0000029644-24-000067.md) | [28.3](/filings/0000029644-25-000098.md) | [78.2](/filings/0000029644-24-000181.md) | [37.7](/filings/0000029644-25-000029.md) | [83.6](/filings/0000029644-25-000058.md) | [31.2](/filings/0000029644-26-000085.md) | [2.5](/filings/0000029644-25-000147.md) | [0.0](/filings/0000029644-26-000026.md) | [10.3](/filings/0000029644-26-000052.md) | [44.8](/filings/0000029644-26-000085.md) | | Shareholders' equity | $m | [1,336](/filings/0000029644-25-000029.md) | [1,376](/filings/0000029644-25-000058.md) | [1,484](/filings/0000029644-25-000058.md) | [1,489](/filings/0000029644-26-000085.md) | [1,543](/filings/0000029644-26-000026.md) | [1,544](/filings/0000029644-26-000052.md) | [1,464](/filings/0000029644-26-000052.md) | [1,454](/filings/0000029644-26-000085.md) | [1,517](/filings/0000029644-26-000026.md) | [1,575](/filings/0000029644-26-000052.md) | [1,695](/filings/0000029644-26-000052.md) | [1,764](/filings/0000029644-26-000085.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Current portion of debt: not reported - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [138](/filings/0000029644-24-000181.md) | [87.0 d](/filings/0000029644-25-000029.md) | [142 d](/filings/0000029644-25-000058.md) | [126 d](/filings/0000029644-26-000085.md) | [72.9](/filings/0000029644-25-000147.md) | [90.4 d](/filings/0000029644-26-000026.md) | [87.7 d](/filings/0000029644-26-000052.md) | [168 d](/filings/0000029644-26-000085.md) | [125](/filings/0000029644-25-000147.md) | [33.0 d](/filings/0000029644-26-000026.md) | [135 d](/filings/0000029644-26-000052.md) | [200 d](/filings/0000029644-26-000085.md) | | Capital expenditure | $m | [23.2](/filings/0000029644-24-000181.md) | [21.3 d](/filings/0000029644-25-000029.md) | [21.3 d](/filings/0000029644-25-000058.md) | [19.8 d](/filings/0000029644-26-000085.md) | [25.1](/filings/0000029644-25-000147.md) | [18.9 d](/filings/0000029644-26-000026.md) | [16.3 d](/filings/0000029644-26-000052.md) | [18.6 d](/filings/0000029644-26-000085.md) | [14.2](/filings/0000029644-25-000147.md) | [15.0 d](/filings/0000029644-26-000026.md) | [23.3 d](/filings/0000029644-26-000052.md) | [14.9 d](/filings/0000029644-26-000085.md) | | Dividends paid | $m | [30.2](/filings/0000029644-24-000181.md) | [30.1 d](/filings/0000029644-25-000029.md) | [30.0 d](/filings/0000029644-25-000058.md) | [32.5 d](/filings/0000029644-26-000085.md) | [32.4](/filings/0000029644-25-000147.md) | [32.2 d](/filings/0000029644-26-000026.md) | [32.3 d](/filings/0000029644-26-000052.md) | [35.0 d](/filings/0000029644-26-000085.md) | [34.7](/filings/0000029644-25-000147.md) | [34.6 d](/filings/0000029644-26-000026.md) | [34.7 d](/filings/0000029644-26-000052.md) | [37.2 d](/filings/0000029644-26-000085.md) | | Share repurchases | $m | [53.3](/filings/0000029644-24-000181.md) | [33.3 d](/filings/0000029644-25-000029.md) | [27.2 d](/filings/0000029644-25-000058.md) | [48.9 d](/filings/0000029644-26-000085.md) | [74.4](/filings/0000029644-25-000147.md) | [7.2 d](/filings/0000029644-26-000026.md) | [191 d](/filings/0000029644-26-000052.md) | [59.3 d](/filings/0000029644-26-000085.md) | [91.5](/filings/0000029644-25-000147.md) | [19.7 d](/filings/0000029644-26-000026.md) | [0.0 d](/filings/0000029644-26-000052.md) | [0.0 d](/filings/0000029644-26-000085.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [124](/filings/0000029644-23-000136.md) | [123](/filings/0000029644-24-000027.md) | [124](/filings/0000029644-24-000067.md) | [123](/filings/0000029644-24-000181.md) | [122](/filings/0000029644-25-000029.md) | [123](/filings/0000029644-25-000058.md) | [122](/filings/0000029644-25-000147.md) | [121](/filings/0000029644-26-000026.md) | [120](/filings/0000029644-26-000052.md) | [118](/filings/0000029644-25-000147.md) | [118](/filings/0000029644-26-000026.md) | [118](/filings/0000029644-26-000052.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 115,910,129 at 2026-09-11, from the cover of the [10-K filed 2026-09-25](/filings/0000029644-26-000085.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.